UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008477
Receipt number R000009452
Scientific Title Clinical study of selegiline hydrochloride ( FP OD tablet 2.5) to flexion of spine in Parkinson's disease.
Date of disclosure of the study information 2012/07/19
Last modified on 2015/09/22 09:15:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study of selegiline hydrochloride ( FP OD tablet 2.5) to flexion of spine in Parkinson's disease.

Acronym

Clinical study of selegiline to flexion of spine in Parkinson's disease.

Scientific Title

Clinical study of selegiline hydrochloride ( FP OD tablet 2.5) to flexion of spine in Parkinson's disease.

Scientific Title:Acronym

Clinical study of selegiline to flexion of spine in Parkinson's disease.

Region

Japan


Condition

Condition

Parkinson disease

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate effectiveness of selegiline hydrochloride (FP OD tablet 2.5) to the flexion of spine associated with Parkinson's disease. We use stabilometory to evaluate it objectively

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Rsults of stabilometry (Gravicoder GS-3000; AeNIMA)

Key secondary outcomes

1. Modified Hoehn & Yahr stage of Parkinson's Disease
2. Iapanese version, UPDRS Part I, Part II, Part III, Part IV
3. Degree of posture flexion (degree of antero flexion/ degree of side flexion) using photo.
4. Pain evaluation with VAS scale.
5. Safety evaluation, side effects.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Selegiline hydrochloride 5mg 8weeks, 7.5mg 8weeks and stop it, followed after 8weeks, and evaluate each points.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients diagnosed as Parkinson' s disease and classified into Modified Hohen & Yahr staging Scale I through
2) Patients whose symptom of posture disorder is latent in supine position
3) Patients aged 20 or over when their consents given
4) Hospitalized patients/outpatients

Key exclusion criteria

1) Patients receiving drugs prohibited for concomitant
2) Patients who have lumber spine deformation evaluated by an X-ray examination
3) Patients whit orthostatic
hypotension
4) Patients receiving medical
treatment for epilepsy
5) Patient who have symptoms of
serious nerve and / or psychiatric
disorders such as disturbance of
consciousness , hallucination ,
delusions and abnormal behavior
6) Patient with severs disease of
heart , blood vessels , liver , renal ,
blood and other life-threatening
diseases
7) Patients who have or had
schizophrenia
8) Patients who have or had addiction to central nerve system stimulants such as cocaine
9) Patients who are pregnant during the period of study
10) Patients addiction to alcohol or drugs
11) Patients who are determined as unfit for the study by attending physicians for reasons other than those stated above

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Asako Yoritaka

Organization

Juntendo Koshigaya Hospital

Division name

Neurology

Zip code


Address

Fukuroyama 560, Koshigaya-shi, Saitama, Japan

TEL

+81-48-975-0321

Email

ayori@juntendo.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Asako Yoritaka

Organization

Juntendo Koshigaya Hospital

Division name

Neurology

Zip code


Address

Fukuroyama 560, Koshigaya-shi, Saitama, Japan

TEL

+81-48-975-0321

Homepage URL


Email

ayori@juntendo.ac.jp


Sponsor or person

Institute

Department of Neurology, Juntendo Koshigaya Hospital

Institute

Department

Personal name



Funding Source

Organization

Department of Neurology, Juntendo Koshigaya Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学附属順天堂越谷病院 神経内科外来


Other administrative information

Date of disclosure of the study information

2012 Year 07 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 05 Month 29 Day

Date of IRB


Anticipated trial start date

2012 Year 07 Month 19 Day

Last follow-up date

2014 Year 12 Month 19 Day

Date of closure to data entry

2015 Year 09 Month 10 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 07 Month 19 Day

Last modified on

2015 Year 09 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009452


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name